Sanat Chattopadhyay, MSD executive vice-president and president of its manufacturing division, said the expansion was “another new chapter in our long-standing legacy in Ireland”
Carlow was MSD’s first vaccines site outside the US when it was opened in 2008. It now operates as a filling site for both new and existing MSD vaccines, biologics medicines and older generation small molecule drugs. Specialising in providing drug substance for clinical trials and early phase development, it is understood to be the US drug giant’s first such plant outside the US. The latest investment was focused on developing a new research facility next to the biologics manufacturing plant in a move the company says will significantly accelerate the time it takes to bring a medicine to market.
대한민국 최근 뉴스, 대한민국 헤드 라인
Similar News:다른 뉴스 소스에서 수집한 이와 유사한 뉴스 기사를 읽을 수도 있습니다.
출처: IrishTimes - 🏆 3. / 98 더 많은 것을 읽으십시오 »